TITLE

News of Science

PUB. DATE
June 1943
SOURCE
New Republic;6/14/43, Vol. 108 Issue 24, p794
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Presents information on the retail marketing of drugs and medications in the U.S. Maintenance of advertising over radio and press by the patent-medicine manufacturers; Complaint against the proprietors of a nationally selling brand; Opinion that a healthy individual requires a laxative no more than he requires a remedy for rheumatism; Disturbance related to vitamin deficiencies among the U.S. people.
ACCESSION #
14682601

 

Related Articles

  • Prescription drug pushers. Sherrid, Pamela // U.S. News & World Report;10/30/2000, Vol. 129 Issue 17, p40 

    Reports on drug patents and drug advertisements which drive up the costs of prescription drugs in the United States. Thought that the manufacturers of today's drugs have become sophisticated marketers; How drug companies began introducing follow-up products before the old drug loses its patent...

  • FROM PRINTING PRESS TO PHARMACEUTICAL REPRESENTATIVE: A SOCIAL HISTORY OF DRUG ADVERTISING AND PROMOTION. Stallings, Shirley // Journal of Drug Issues;Spring92, Vol. 22 Issue 2, p205 

    With only a few years left in the twentieth century, a multiplicity of controversies encompass drug advertising and promotion. Have marketing techniques regarding pharmaceutical drugs, proprietary medicines, alcohol, and tobacco really changed over time and disrupted the value structure of...

  • CURBING THE DRUG MARKETERS. Fonda, Daren; Kiviat, Barbara; Bjerklie, David; Rawe, Julie; Friedhoff, Stefanie; Roston, Eric; Thornburgh, Nathan // Time;7/5/2004, Vol. 164 Issue 1, p40 

    Offers a look at the pharmaceutical industry's marketing techniques following a rise of regulations on the sale and illegal marketing of drugs for off-label uses not approved by the United States Food and Drug Administration. Report on the large presence of pharmaceutical lobbyists in the U.S.;...

  • Generics on the Go.  // Pharmaceutical Executive;Oct2007, Vol. 27 Issue 10, pS12 

    The article focuses on continuous growth of non-branded generics among market segments in Brazil. The generics sector's share of the Braizilian market reached 10.26 percent in the year ending May 2006. The government introduced a number of high-profile initiatives to promote off-patent,...

  • Algesal.  // Royal Society of Medicine: Medicines;2002, p43 

    The article presents information on Algesal, a proprietary, non-prescription preparation of diethylamine salicylate, which has a counter-irritant, or rubefacient, action. It can be applied to the skin for the symptomatic relief of musculoskeletal rheumatic conditions. Available as a cream,...

  • Radio tuned into DTC; spending up 27%. Krisanits, Tracv // Medical Marketing & Media;Sep2004, Vol. 39 Issue 9, p30 

    The article reports that the robust growth seen in DTC advertisements spending has not been limited to television. Radio also has been an important vehicle for pharmaceutical marketing. According to new data released by the Radio Advertising Bureau, spending in the medicines and proprietary...

  • Report from: India. Nair, A. // Pharmaceutical Technology;Feb2011, Vol. 35 Issue 2, p18 

    The article looks at the move of drug companies in India to deal with global manufacturers for commercialization of follow-on biologics before the expiration of drug patents in the U.S. It reports on the deal between Pfizer Inc. and Bangalore-based Biocon to market insulin products that will be...

  • Biosimilars: initial excitement gives way to reality. Belsey, Mark J.; Harris, Laura M.; Das, Romita R.; Chertkow, Joanna // Nature Reviews Drug Discovery;Jul2006, Vol. 5 Issue 7, p535 

    The article presents information on the challenges, and the new marketing approaches of innovative drug developers in the United States. The focus on cost containment of drugs has increased the sales growth in generics. Datamonitor estimates that its sales which was approximately US$157 billion...

  • NEWS BRIEFS.  // MondayMorning;3/22/2010, Vol. 18 Issue 11, p5 

    The article offers news briefs related to the pharmaceutical industry. British drugmaker AstraZeneca PLC has stated that it has won the first trial brought by a patient alleging its psychiatric drug Seroquel caused harm. The leading drugmakers are needed to move quickly to adapt to a new world...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics